- Home
- TRT vs ELUT Comparison
TRT vs ELUT Comparison
Compare TRT & ELUT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | TRT | ELUT |
|---|---|---|
| Founded | 1958 | 2015 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Industrial Machinery/Components | Medical Specialities |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 50.6M | 48.3M |
| IPO Year | 1995 | 2020 |
Fundamental Metrics
Financial Performance| Metric | TRT | ELUT |
|---|---|---|
| Price | $12.86 | $1.07 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 1 |
| Target Price | N/A | ★ $6.00 |
| AVG Volume (30 Days) | ★ 2.2M | 106.2K |
| Earning Date | 05-13-2026 | 05-08-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 146.77 |
| EPS | 0.02 | ★ 0.87 |
| Revenue | ★ $32,462,000.00 | $12,293,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | $10.83 |
| P/E Ratio | $615.00 | ★ $1.17 |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $4.42 | $0.50 |
| 52 Week High | $19.10 | $2.60 |
Technical Indicators
Market Signals| Indicator | TRT | ELUT |
|---|---|---|
| Relative Strength Index (RSI) | 58.11 | 50.18 |
| Support Level | $5.75 | $1.00 |
| Resistance Level | $14.78 | $1.18 |
| Average True Range (ATR) | 2.97 | 0.07 |
| MACD | -0.11 | -0.00 |
| Stochastic Oscillator | 47.39 | 43.10 |
Price Performance
Historical ComparisonAbout TRT Trio-Tech International
Trio-Tech International is a provider of reliability test equipment and services to the semiconductor and other industries. Its customers are from automotive electronics, industrial electronics, computing and data storage, consumer electronics, and communication markets. The company operated its business in two segments: Semiconductor Back-end Solutions and Industrial Electronics. Geographically, the company operates in the United States (U.S), Singapore, Malaysia, Thailand and China.
About ELUT Elutia Inc.
Elutia Inc develops proprietary drug-eluting biomatrix products for use in surgical reconstruction and related applications. These products are designed to improve the interaction between implanted medical devices and patients. Its products include CanGaroo, designed for implantable electronic devices, and SimpliDerm, used in soft tissue repair, with functions related to implant support and wound management. The company operates in two segments: Women's Health and Cardiovascular. The majority of revenue is derived from the Women's Health segment.